<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01835340</url>
  </required_header>
  <id_info>
    <org_study_id>NCT01835340</org_study_id>
    <nct_id>NCT01835340</nct_id>
  </id_info>
  <brief_title>Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures</brief_title>
  <official_title>Study to Estimate Central Propofol Effect by Measuring Exhaled Propofol Concentrations in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Draeger</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Luebeck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol can be measured continuously in breath gas during anesthesia. This study compares
      propofol concentration in plasma and breath gas and processed electroencephalographic
      monitoring (bispectral index) under clinical conditions with patients and total intravenous
      anesthesia. Target controlled infusion technique is used to deliver adequate propofol
      concentration in plasma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 9, 2017</completion_date>
  <primary_completion_date type="Actual">December 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exhaled propofol (parts per billion)</measure>
    <time_frame>Continuous measurement over 40 min during the induction of anesthesia and 30 min during recovery of anesthesia</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Urological Disease</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol Patients will receive propofol anesthesia on the study day</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug: Propofol Anesthesia Patients will undergo propofol anesthesia.</intervention_name>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ 18 years of age

          -  Written informed consent

          -  Ability and willingness to give written informed consent

          -  American Society of Anesthesiologists (ASA) risk score I-II

        Exclusion Criteria:

          -  Denial of the patient

          -  Patients ASA physical status III- IV

          -  Pregnancy

          -  Volunteers with history of neurological disease or stroke

          -  Volunteers with a history of recreational drug abuse

          -  Volunteers with a history of alcohol abuse

          -  Known drug allergies

          -  History of adverse events during general anesthesia

          -  Total intravenous anesthesia not practicable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hartmut Gehring, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Luebeck</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Anesthesiology and Intensive Care</name>
      <address>
        <city>Luebeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Grossherr M, Hengstenberg A, Meier T, Dibbelt L, Igl BW, Ziegler A, Schmucker P, Gehring H. Propofol concentration in exhaled air and arterial plasma in mechanically ventilated patients undergoing cardiac surgery. Br J Anaesth. 2009 May;102(5):608-13. doi: 10.1093/bja/aep053. Epub 2009 Mar 31.</citation>
    <PMID>19336539</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2013</study_first_submitted>
  <study_first_submitted_qc>April 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2013</study_first_posted>
  <last_update_submitted>December 9, 2017</last_update_submitted>
  <last_update_submitted_qc>December 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Luebeck</investigator_affiliation>
    <investigator_full_name>Martin Grossherr</investigator_full_name>
    <investigator_title>PhD, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urologic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

